合成ゲノミクス市場の2030年までの予測：製品別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の合成ゲノミクス市場は2023年に303億米ドルを占め、予測期間中のCAGRは14.6％で成長し、2030年には787億米ドルに達すると予測されています。

急速に成長している合成生物学は、遺伝物質の生産と操作を伴う分野であり、合成ゲノミクス市場に含まれます。この分野では、遺伝子組み換え生物、人工細胞、テーラーメイド遺伝子回路の作成など、さまざまな用途のために合成DNA配列の作成、構築、改良が行われます。合成ゲノミクスは、医薬品開発、遺伝子治療、医療分野におけるオーダーメイド医療に不可欠です。農業の分野では、より優れた特性を持つ遺伝子組み換え作物の作出を助ける。

世界経済フォーラムが2021年9月に発表したデータによると、合成生物学の進歩は、ウイルスに対するmRNAワクチンの開発のためにパンデミックを管理する大きな可能性を秘めています。

研究開発への投資の拡大

合成ゲノミクスの急速な発展に伴い、イノベーションと新技術を促進するための研究開発への追加資金が必要とされています。これらの投資は、DNA合成、遺伝子編集、その他の遺伝物質操作のための最先端手法の検討に資金を提供しています。さらに、研究イニシアティブに対する財政的支援の拡大は、官民双方がヘルスケア、農業、産業応用における合成ゲノムの巨大な可能性を認識した結果です。

高い研究開発費

遺伝子工学は複雑で最先端の技術が要求されるため、中小企業や研究機関は市場への参入が難しいと考えられています。高度な遺伝子編集ツール、DNA合成技術、その他の重要な技術を生み出すには多額の資金が必要であり、そのため多くの人がこの分野で働くことができないです。しかし、企業が合成ゲノミクスを探求し革新する能力は、多額の初期投資と継続的な研究開発コストによって制約を受ける可能性があります。

合成生物学ソリューションに対する需要の高まり

合成生物学の基本的側面である合成ゲノミクスは、さまざまな分野で革新的で適応性の高い生物学的ソリューションに対する需要の高まりに貢献しています。企業や教育機関が、合成ゲノミクスが遺伝物質の創出や改変に大きな可能性を秘めていることを認識するにつれ、カスタマイズされた生物学的システムの需要がますます高まっています。この需要の用途は幅広く、産業バイオテクノロジー、ヘルスケア、農業などが含まれます。さらに、合成ゲノミクスを用いることで、生物は、工業プロセス用のバイオベース材料の作成、改良された特徴を持つ遺伝子組み換え作物、薬物治療など、特定の職務を行うように設計することができます。

安全保障とバイオセキュリティへの懸念

悪意のある目的のために合成ゲノミクスが利用されるのではないかという懸念は、遺伝物質の操作や合成生物の生産の可能性によって引き起こされます。こうした懸念を和らげるために、政府や規制機関は、遺伝子技術への違法なアクセスを禁止する厳格な法律を制定しなければならないです。生物兵器のような悪意を持った遺伝子組み換え生物が作られる可能性があるため、効果的な安全予防措置が必要です。しかし、合成ゲノム市場の企業は、こうした懸念の結果、コンプライアンス要件を管理することが困難であり、規制当局の承認プロセスを遅らせ、監視の目を厳しくしています。

COVID-19影響：

ワクチン開発、診断、代替治療における最先端の遺伝子技術の妥当性は、世界の健康危機によって実証されています。mRNAワクチン接種の迅速な開発は、合成ゲノミクスによって可能となり、この技術が新たな感染症に迅速に適応できることを実証しました。パンデミックは、研究イニシアチブを遅らせ、サプライチェーンを逆転させ、緊急のヘルスケア要件にリソースを振り向けることで、市場の成長軌道に間接的な影響を及ぼしました。資金調達の制限と経済の不確実性は、業界の小規模な参加者に影響を与えました。

DNAテンプレート分野は予測期間中最大となる見込み

遺伝物質を正確かつ効果的に合成する上で極めて重要であることから、DNAテンプレート分野は合成ゲノム市場で最大のシェアを占めています。自動DNA合成プラットフォームや革新的なアプローチを含むDNA合成技術の進歩により、調査やバイオテクノロジーの研究者は、これまで達成できなかったスピードと精度でカスタマイズされたDNA配列を設計・製造できるようになった。さらに、遺伝子治療、創薬、遺伝子組み換え家畜の作出など、さまざまな用途で合成生物学的ソリューションへのニーズが高まっていることも、DNAテンプレート分野の上昇を引き起こしている要因です。

予測期間中にCAGRが最も高くなると予想されるのは臓器移植分野です。

臓器移植は、臓器不足に関連する課題に対処する上で変革的な効果をもたらすため、この分野は予測期間中に収益性の高い成長が見込まれます。臓器拒絶反応や臓器不足に関連する問題に対処するため、合成ゲノミクスは、互換性を向上させた臓器や組織を生産する効率的な方法として登場しました。さらに、臓器を遺伝子工学的に正確に改変する能力は、特定の患者向けに移植片をカスタマイズし、免疫学的反応を抑え、移植成功率を高める可能性を提供します。

最大のシェアを占める地域：

予測期間中、アジア太平洋地域が市場で最大のシェアを占めていました。これは、同地域の経済が急速な工業化と技術向上を遂げていることに加え、多くの分野で合成ゲノミクスの革命的な可能性に対する認識が高まっているためです。中国、日本、インドなどの国々が大規模な研究開発投資を行い、合成ゲノミクスの開発に最適な環境を作り出しています。最先端のイニシアチブは、学術機関、研究機関、バイオテクノロジー企業によって積極的に推進されており、イノベーションと新しいアプリケーションの創出を促進しています。

CAGRが最も高い地域：

精密医療とオーダーメードヘルスケアへの注目が高まる中、アジア太平洋地域はヘルスケア関連プロジェクトの増加により収益性の高い成長を遂げています。遺伝子介入、遺伝子治療、診断ツールのカスタマイズが可能になるため、合成ゲノミクスはこうした取り組みに不可欠です。合成ゲノミクス技術の利用は、地域の健康問題に対処し、カスタマイズされた薬物療法を提供できる可能性があることから推進されています。さらに、シンガポールや中国のような国の政府は、合成生物学やバイオテクノロジーの領域での取り組みを積極的に支援しており、これらの分野の研究開発の進展を支援するための資源やインフラを提供しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の合成ゲノミクス市場：製品別

• アダプター
• DNAテンプレート
• クレノウの破片
• 酵素の修飾
• プライマー
• その他の製品

第6章 世界の合成ゲノミクス市場：用途別

• 細菌耐性
• DNAプリンティング
• 革新的なワクチンと治療法
• 栄養タンパク質と油
• 臓器移植
• その他の用途

第7章 世界の合成ゲノミクス市場：エンドユーザー別

• 学術機関
• バイオテクノロジー企業
• 受託研究機関
• 政府研究所
• 製薬会社
• その他のエンドユーザー

第8章 世界の合成ゲノミクス市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Biocompare Inc
• Boster Biological Technology
• Eurofins Genomics
• Genewiz
• GenScript
• Integrated DNA Technologies Inc
• Synthetic Genomics Inc
• Thermo Fisher Scientific Inc
• Twist Bioscience

List of Tables

• Table 1 Global Synthetic Genomics Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 4 Global Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 5 Global Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 6 Global Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 7 Global Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 8 Global Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 9 Global Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 10 Global Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 11 Global Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 12 Global Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 13 Global Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 14 Global Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 15 Global Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 Global Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 17 Global Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 18 Global Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 19 Global Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 20 Global Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 21 Global Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 22 Global Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 23 North America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
• Table 24 North America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 25 North America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 26 North America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 27 North America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 28 North America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 29 North America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 30 North America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 31 North America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 32 North America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 33 North America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 34 North America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 35 North America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 36 North America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 37 North America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 38 North America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 39 North America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 40 North America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 41 North America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 42 North America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 43 North America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 44 North America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 45 Europe Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
• Table 46 Europe Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 47 Europe Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 48 Europe Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 49 Europe Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 50 Europe Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 51 Europe Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 52 Europe Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 53 Europe Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 54 Europe Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 55 Europe Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 56 Europe Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 57 Europe Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 58 Europe Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 59 Europe Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 60 Europe Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 61 Europe Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 62 Europe Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 63 Europe Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 64 Europe Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 65 Europe Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 66 Europe Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 67 Asia Pacific Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
• Table 68 Asia Pacific Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 69 Asia Pacific Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 70 Asia Pacific Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 71 Asia Pacific Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 72 Asia Pacific Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 73 Asia Pacific Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 74 Asia Pacific Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 75 Asia Pacific Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 76 Asia Pacific Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 77 Asia Pacific Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 78 Asia Pacific Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 79 Asia Pacific Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 80 Asia Pacific Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 81 Asia Pacific Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 82 Asia Pacific Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 83 Asia Pacific Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 84 Asia Pacific Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 85 Asia Pacific Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 86 Asia Pacific Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 87 Asia Pacific Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 88 Asia Pacific Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 89 South America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
• Table 90 South America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 91 South America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 92 South America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 93 South America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 94 South America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 95 South America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 96 South America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 97 South America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 98 South America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 99 South America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 100 South America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 101 South America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 102 South America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 103 South America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 104 South America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 105 South America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 106 South America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 107 South America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 108 South America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 109 South America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 110 South America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 111 Middle East & Africa Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
• Table 112 Middle East & Africa Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
• Table 113 Middle East & Africa Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
• Table 114 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
• Table 115 Middle East & Africa Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
• Table 116 Middle East & Africa Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
• Table 117 Middle East & Africa Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
• Table 118 Middle East & Africa Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
• Table 119 Middle East & Africa Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
• Table 120 Middle East & Africa Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
• Table 121 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
• Table 122 Middle East & Africa Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
• Table 123 Middle East & Africa Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
• Table 124 Middle East & Africa Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 125 Middle East & Africa Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 126 Middle East & Africa Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
• Table 127 Middle East & Africa Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
• Table 128 Middle East & Africa Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
• Table 129 Middle East & Africa Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
• Table 130 Middle East & Africa Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
• Table 131 Middle East & Africa Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
• Table 132 Middle East & Africa Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Synthetic Genomics Market is accounted for $30.3 billion in 2023 and is expected to reach $78.7 billion by 2030 growing at a CAGR of 14.6% during the forecast period. The rapidly growing field of synthetic biology, which involves the production and manipulation of genetic material, is included in the Synthetic Genomics Market. It involves the creation, building, and refinement of synthetic DNA sequences for a variety of applications, including the creation of genetically modified creatures, artificial cells, and tailored genetic circuits. Synthetic genomics is essential to drug development, gene therapy, and customized medicine in the field of medicine. It aids in the creation of genetically engineered crops with enhanced attributes in agriculture.

According to a data published by the World Economic Forum in September 2021, the advancements in the synthetic biology have a vast potential to manage the pandemic for the development of mRNA vaccine against virus.

Market Dynamics:

Driver:

Growing investments in research and development activities

As synthetic genomics develops rapidly, additional funding for research and development is needed to promote innovation and new technologies. These investments fund the examination of cutting-edge methods for DNA synthesis, gene editing, and other genetic material manipulation. Additionally, growing financial support for research initiatives is a result of both the public and private sectors recognizing the enormous potential of synthetic genomes in healthcare, agriculture, and industrial applications.

Restraint:

High costs of research and development

Due to the complexity of genetic engineering and the requirement for cutting-edge technologies, smaller businesses and research institutions consider it difficult to enter the market. Significant money is needed to create advanced gene editing tools, DNA synthesis techniques, and other critical technologies, which prevents numerous individuals from working in this field. However, companies' capacity to explore and innovate in synthetic genomics may be constrained by the significant initial investment and ongoing research and development costs.

Opportunity:

Rising demand for synthetic biology solutions

Synthetic genomics, a fundamental aspect of synthetic biology, contributes to the growing demand for innovative and adaptable biological solutions in a range of sectors. Customized biological systems are becoming more and more in demand as companies and educational institutions realize the enormous promise synthetic genomics has for creating and modifying genetic material. Applications for this demand are wide-ranging and include industrial biotechnology, healthcare, and agriculture. Moreover, with the use of synthetic genomics, biological organisms can be designed to do specific duties, such as creating bio-based materials for industrial processes, genetically modified crops with improved features, and medicinal treatments.

Threat:

Security and biosecurity concerns

Fears regarding the exploitation of synthetic genomics for malevolent terminates are triggered by the manipulation of genetic material and the potential production of synthetic creatures. To mitigate these worries, governments and regulatory agencies must impose stringent laws that prohibit illegal access to genetic technologies. Effective safety precautions are necessary due to the possibility of creating genetically modified organisms with malicious intent, such as bioweapons. However, companies in the synthetic genome market find it difficult to manage compliance requirements as a result of these worries, which also slow down the regulatory approval process and raise scrutiny.

COVID-19 Impact:

The relevance of cutting-edge genetic technologies for vaccine development, diagnostics, and treatment alternatives has been demonstrated by the global health crisis. The rapid development of mRNA vaccinations was made possible by synthetic genomics, demonstrating the technology's capacity to adapt rapidly to new infections. The pandemic managed to indirectly affect the market's growth trajectory by delaying research initiatives, reversing supply chains, and directing resources to urgent healthcare requirements. Funding limitations and economic uncertainty had an impact on the industry's smaller participants.

The DNA template segment is expected to be the largest during the forecast period

Due to its crucial significance in the accurate and effective synthesis of genetic material, the DNA template segment held the largest share in the synthetic genomics market. Researchers and biotechnologists can design and manufacture customized DNA sequences with previously unattainable speed and accuracy because of advancements in DNA synthesis technology, including automated DNA synthesis platforms and innovative approaches. Furthermore, the growing need for synthetic biology solutions for a variety of applications, such as gene therapy, drug discovery, and the generation of genetically modified livestock, is the factor that is causing this rise in the DNA template sector.

The organ transplantation segment is expected to have the highest CAGR during the forecast period

Because organ transplantation has a transformative effect on addressing the challenges associated with organ shortages, the segment is expected to grow profitably during the projected period. To address the issues associated with organ rejection and scarcity, synthetic genomics has emerged as a potentially efficient way of producing organs and tissues with improved compatibility. Additionally, the capacity to precisely modify organs genetically offers the possibility of customizing grafts for particular patients, reducing immunological reactions, and raising transplant success rates.

Region with largest share:

Over the course of the projected period, the Asia Pacific region had the largest share of the market due to the region's economies experiencing rapid industrialization and technological improvement, as well as the increasing awareness of the revolutionary potential of synthetic genomics across numerous sectors. Significant R&D investments have been made by nations like China, Japan, and India, creating an optimal environment for the development of synthetic genomics. Cutting-edge initiatives are being actively promoted by academic institutions, research organizations, and biotech corporations, which promote innovation and the creation of new applications.

Region with highest CAGR:

With an increasing focus on precision medicine and tailored healthcare, the Asia-Pacific area is experiencing profitable growth as a result of an increase in healthcare-related projects. Because it renders it feasible to customize genetic interventions, gene therapies, and diagnostic tools, synthetic genomics is essential to these initiatives. The use of synthetic genomics technology is being propelled by its potential to address regional health concerns and offer customized medicinal therapies. Moreover, governments in nations like Singapore and China are actively supporting efforts in the domains of synthetic biology and biotechnology, offering resources and infrastructure to support the advancement of these fields' research and development.

Key players in the market:

Some of the key players in Synthetic Genomics market include Biocompare Inc , Boster Biological Technology, Eurofins Genomics, Genewiz, GenScript, Integrated DNA Technologies Inc, Synthetic Genomics Inc, Thermo Fisher Scientific Inc and Twist Bioscience .

Key Developments:

In October 2023, Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company's 35-year-history-its entrance into the therapeutics space-and enables IDT to manufacture products for research use through to current good manufacturing practice (cGMP) grade cell and gene therapy reagents to provide researchers with a single partner that can help them rapidly transition from the lab to therapeutic development.

In February 2023, Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.

In February 2023, Twist Bioscience announces technology early access of enhanced whole genome sequencing solution at AGBT. eWGS is a novel solution that enables researchers to obtain simultaneous low-pass whole genome data together with deep coverage of selected regions, in a high-throughput and cost-effective workflow.

Products Covered:

• Adapters
• DNA Template
• Klenow Fragment
• Modifying Enzymes
• Primers
• Other Products

Applications Covered:

• Bacterial Resistance
• DNA Printing
• Innovative Vaccines & Therapeutics
• Nutritional Proteins & Oils
• Organ Transplantation
• Other Applications

End Users Covered:

• Academic Institutions
• Biotechnology Companies
• Contract Research Organizations
• Government Laboratories
• Pharmaceutical companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Synthetic Genomics Market, By Product

• 5.1 Introduction
• 5.2 Adapters
• 5.3 DNA Template
• 5.4 Klenow Fragment
• 5.5 Modifying Enzymes
• 5.6 Primers
• 5.7 Other Products

6 Global Synthetic Genomics Market, By Application

• 6.1 Introduction
• 6.2 Bacterial Resistance
• 6.3 DNA Printing
• 6.4 Innovative Vaccines & Therapeutics
• 6.5 Nutritional Proteins & Oils
• 6.6 Organ Transplantation
• 6.7 Other Applications

7 Global Synthetic Genomics Market, By End User

• 7.1 Introduction
• 7.2 Academic Institutions
• 7.3 Biotechnology Companies
• 7.4 Contract Research Organizations
• 7.5 Government Laboratories
• 7.6 Pharmaceutical companies
• 7.7 Other End Users

8 Global Synthetic Genomics Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Biocompare Inc
• 10.2 Boster Biological Technology
• 10.3 Eurofins Genomics
• 10.4 Genewiz
• 10.5 GenScript
• 10.6 Integrated DNA Technologies Inc
• 10.7 Synthetic Genomics Inc
• 10.8 Thermo Fisher Scientific Inc
• 10.9 Twist Bioscience